Cargando…

Physiologically‐based pharmacokinetic modeling of oxcarbazepine and levetiracetam during adjunctive antiepileptic therapy in children and adolescents

Oxcarbazepine (OXZ) and levetiracetam (LEV) are two new generation anti‐epileptic drugs, often co‐administered in children with enzyme‐inducing antiepileptic drugs (EIAEDs). The anti‐epileptic effect of OXZ and LEV are linked to the exposure of OXZ’s active metabolite 10‐monohydroxy derivative (MHD)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sinha, Jaydeep, Karatza, Eleni, Gonzalez, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846633/ https://www.ncbi.nlm.nih.gov/pubmed/34816634 http://dx.doi.org/10.1002/psp4.12750

Ejemplares similares

Effects of levetiracetam and oxcarbazepine monotherapy on intellectual and cognitive development in children with benign epilepsy with centrotemporal spikes
por: Suo, Gui-hai, et al.
Publicado: (2021)

Application of Physiologically Based Pharmacokinetic Modeling to Predict Maternal Pharmacokinetics and Fetal Exposure to Oxcarbazepine
por: He, Lixia, et al.
Publicado: (2022)

Effect of Penetration Enhancers on Transdermal Delivery of Oxcarbazepine, an Antiepileptic Drug Using Microemulsions
por: Virani, Amitkumar, et al.
Publicado: (2023)

Levetiracetam Liver Injury: A Benign Antiepileptic Agent?
por: Hegazy, Yassmin, et al.
Publicado: (2023)

The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine
por: Maschio, Marta, et al.
Publicado: (2009)

Additional Antiepileptic Mechanisms of Levetiracetam in Lithium-Pilocarpine Treated Rats
por: Al-Shorbagy, Muhammad Y., et al.
Publicado: (2013)

Effectiveness and Safety of Oxcarbazepine vs. Levetiracetam as Monotherapy for Infantile Focal Epilepsy: A Longitudinal Cohort Study
por: Zhao, Binyang, et al.
Publicado: (2022)

Levetiracetam versus Oxcarbazepine as monotherapy in newly diagnosed focal epilepsy: A systematic review and meta‐analysis
por: Kharel, Sanjeev, et al.
Publicado: (2022)

Thermoresponsive Gel-loaded Oxcarbazepine Nanosystems for Nose- To-Brain Delivery: Enhanced Antiepileptic Activity in Rats
por: Abou-Taleb, Basant A., et al.
Publicado: (2023)

Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy
por: de MANREZA, Maria Luiza Giraldes, et al.
Publicado: (2021)

The antiepileptic drug levetiracetam improves auditory gating in DBA/2 mice
por: Smucny, Jason, et al.
Publicado: (2015)

Effects of Oxcarbazepine and Levetiracetam on Calcium, Ionized Calcium, and 25-OH Vitamin-D3 Levels in Patients with Epilepsy
por: Aksoy, Duygu, et al.
Publicado: (2016)

Characterizing Pharmacokinetics in Children With Obesity—Physiological, Drug, Patient, and Methodological Considerations
por: Gerhart, Jacqueline G., et al.
Publicado: (2022)

Lacosamide and sodium channel‐blocking antiepileptic drug cross‐titration against levetiracetam background therapy
por: Baulac, M., et al.
Publicado: (2016)

Neuropsychological implications of adjunctive levetiracetam in childhood epilepsy
por: Posar, Annio, et al.
Publicado: (2014)

Antiepileptic Drug of Levetiracetam Decreases Centrotemporal Spike-Associated Activation in Rolandic Epilepsy
por: Zhang, Qirui, et al.
Publicado: (2018)

The Antiepileptic Drug Oxcarbazepine Inhibits the Growth of Patient-Derived Isocitrate Dehydrogenase Mutant Glioma Stem-like Cells
por: Dao Trong, Philip, et al.
Publicado: (2023)

Modulation of Antioxidant Enzymatic Activities by Certain Antiepileptic Drugs (Valproic Acid, Oxcarbazepine, and Topiramate): Evidence in Humans and Experimental Models
por: Cárdenas-Rodríguez, Noemí, et al.
Publicado: (2013)

Clinical Pharmacology and Pharmacokinetics of Levetiracetam
por: Wright, Chanin, et al.
Publicado: (2013)

Oxcarbazepine and Hyponatremia
por: Čiauškaitė, Julija, et al.
Publicado: (2022)

Assessment of the biomarkers of hepatotoxicity following carbamazepine, levetiracetam, and carbamazepine-levetiracetam adjunctive treatment in male Wistar rats
por: Osuntokun, Opeyemi Samson, et al.
Publicado: (2021)

Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel
por: Hansen, Cerine C., et al.
Publicado: (2018)

Oxcarbazepine Therapy for Complete Central Diabetes Insipidus
por: Abdallah, Basmah, et al.
Publicado: (2018)

First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid
por: van der Meer, Pim B., et al.
Publicado: (2021)

Efficacy comparison of oxcarbazepine and levetiracetam monotherapy among patients with newly diagnosed focal epilepsy in China: A multicenter, open‐label, randomized study
por: Zhu, Haoyue, et al.
Publicado: (2022)

Functional Connectivity Derived From Electroencephalogram in Pharmacoresistant Epileptic Encephalopathy Using Cannabidiol as Adjunctive Antiepileptic Therapy
por: Morales Chacón, Lilia Maria, et al.
Publicado: (2021)

Psychiatric Symptoms and Quality of Life in Patients with Drug-Refractory Epilepsy Receiving Adjunctive Levetiracetam Therapy
por: Lee, Jang-Joon, et al.
Publicado: (2011)

Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma
por: Sulsenti, Roberta, et al.
Publicado: (2021)

Physiologically based pharmacokinetic modeling of levetiracetam to predict the exposure in hepatic and renal impairment and elderly populations
por: Shen, Chaozhuang, et al.
Publicado: (2023)

Pharmacokinetic characteristics of antiepileptic drugs (AEDs)
por: Marvanova, Marketa
Publicado: (2016)

Pre- and Post-Treatment with Novel Antiepileptic Drug Oxcarbazepine Exerts Neuroprotective Effect in the Hippocampus in a Gerbil Model of Transient Global Cerebral Ischemia
por: Ahn, Ji Hyeon, et al.
Publicado: (2019)

Long‐term efficacy and safety of adjunctive extended‐release oxcarbazepine (Oxtellar XR(®)) in adults with partial‐onset seizures
por: Chung, S. S., et al.
Publicado: (2015)

Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling
por: Gerhart, Jacqueline G., et al.
Publicado: (2021)

Uncontrolled headache induced by oxcarbazepine
por: Piovesan, Elcio Juliato, et al.
Publicado: (2007)

Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy
por: Yi, Jia-Qin, et al.
Publicado: (2023)

Experience and pharmacokinetics of Levetiracetam in Korean neonates with neonatal seizures
por: Shin, Jae Won, et al.
Publicado: (2017)

Effect of date molasses on levetiracetam pharmacokinetics in healthy rats
por: Abu Dayyih, Wael, et al.
Publicado: (2023)

Use of Real‐World Data and Physiologically‐Based Pharmacokinetic Modeling to Characterize Enoxaparin Disposition in Children With Obesity
por: Gerhart, Jacqueline G., et al.
Publicado: (2022)

Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial
por: French, JA, et al.
Publicado: (2014)

Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsy
por: Jang, Yoonhyuk, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5hupc2oclat79880eescgvako4